{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT02730312: Phase 1 Interventional Completed Acute Myelogenous Leukemia
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03517488: Phase 1 Interventional Completed Melanoma
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:relfovetmab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT04134468: Phase 2 Interventional Withdrawn Pancreatic Ductal Adenocarcinoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03585803: Phase 1 Interventional Completed Acute Radiation Syndrome
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02858895: Phase 2 Interventional Completed Glioblastoma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:livmoniplimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04232033: Not Applicable Interventional Completed Fibroblast Growth Factor 21
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04619602: Phase 1 Interventional Suspended Bronchopulmonary Dysplasia
(2025)
Source URL:
Class:
PROTEIN
